$0.1743
-0.00150-0.85%
At close: -
$0.1750
0.000700.40%
After Hours: Feb 21, 6:12 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Syros Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.